“Oncoplastic Breast Reduction Surgery Decreases Rates of Reoperation with No Increased Medical Risk”

The purpose of this study is to compare the oncologic, medical, and surgical outcomes of lumpectomy versus oncoplastic breast reduction surgery (OBRS) on a national scale. A national insurance-based database was queried for patients who had a lumpectomy with or without a same-day breast reduction by CPT codes. Patients were then matched by obesity, BMI range, age, region, neoadjuvant chemotherapy, and outcomes were compared.There were 421,455 patients in the lumpectomy group and 15,909 patients in the OBRS group.

Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - November 4, 2023 Category: Cosmetic Surgery Authors: Lee H. Kilmer, Allan A. Weidman, Brent R. DeGeorge, John T. Stranix, Chris A. Campbell Source Type: research